Maple Leaf Green World (OTCQB:MGWFF,NEO:MGW) CEO Raymond Lai believes there are vast opportunities for cannabis companies tied to the growth of the North American markets.

In the interview below, Lai discusses the company’s facilities in BC, Nevada and California, the first of which will be completed within this year. Using its experience in eco-agriculture and greenhouse management, the company’s management team plans to position Maple Leaf Green World as a key cultivator for the medicinal and recreational cannabis markets.

Below is a transcript of our interview with Maple Leaf Green World CEO Raymond Lai. It has been edited for clarity and brevity.

Investing News Network: Please give our investor audience an overview of Maple Leaf.

Maple Leaf Green World CEO Raymond Lai: Maple Leaf Green World is a North American company concentrated on the cannabis sector. Our main focus is on providing cannabis-derived oil for medical use, as well as offering safe and high-quality cannabis for adult use. We have extensive greenhouse management experience, eco-agricultural knowledge and cultivation technology that can be applied directly to the production of high-quality cannabis products.

INN: How has Maple Leaf been developing its presence in the North American cannabis industry? Does the company have plans to expand to the international market?

RL: We currently have three projects which include Telkwa, BC; Henderson, Nevada; and Riverside County, California. Construction at our BC project will be completed before year end and our Nevada facility shortly thereafter. Upon completion, we will have over 47,000 square feet under roof. Immediately following, we plan to add 10 additional greenhouses to our property in California, giving us over 80,000 square feet under roof. Once these projects are completed, we will look to expand globally by exporting to countries where medical cannabis has been legalized.

INN: What is next for Maple Leaf and how does that fit into the company’s long-term plans?

RL: The completion of our projects in BC and Nevada will be a major milestone for us. This will enable us to begin cannabis cultivation and sales. Legalization of Canada’s recreational cannabis is set to occur in October of this year. This will not only open up a huge market for us, but it will also bring a lot of attention, legitimacy and advocacy to the medical benefits of cannabis. This is going to be a major industry and we have a lot of room to grow, both geographically and as a public company.

INN: Will the company’s primary focus be on medical or recreational cannabis?

RL: Maple Leaf’s primary focus is on medical cannabis to help patients achieve a quality of life. We are concentrated on producing high-quality cannabis and cannabis-derived oils and ultimately exporting these products to other countries that have legalized medical cannabis programs in place. However, with recreational cannabis soon to be legalized in Canada and already legalized in a number of states in the US, we also plan to launch recreational cannabis brands focused on providing a variety of products to market in both Canada and the US.

INN: How does Maple Leaf stand out within the medicinal cannabis industry?

RL: One of our advantages is our experience. We started off as an eco-agricultural company, allowing us to leverage over a decade of greenhouse management experience and cultivation technology that can be used directly for the production of high-quality cannabis products. We have also retained and are in the process of retaining a few key individuals with vast amounts of knowledge and experience in indoor cannabis cultivation. In addition, we believe we have a huge geographic advantage. Our land holdings in BC, Nevada and California have positioned the company strategically so that we can promptly respond to demand in both the medical and recreational cannabis markets in both Canada and the US.

INN: What other upcoming catalysts can investors expect for Maple Leaf?

RL: We will be making various announcements regarding the start of cultivation and production after our facilities are completed. This will include the sale of products, adding additional partners and entering into new markets to ultimately expand globally. We are really looking forward to seeing the continuous growth of our business and the rapid growth of the market.

CEO interviews are part of investor education campaigns for clients advertising on the Investing News Network. Important news is contextualized by CEOs, and the resulting interviews are disseminated to the Investing News Network audience because they have value to market watchers.

The Investing News Network interviews a CEO for an understanding of their perspective on the company, the investment potential of the company and market news related to the company. The information contained here is for information purposes only and is not to be construed as an offer or solicitation for the sale or purchase of securities. 

  • Company has received UK Continuing Professional Development (“CPD”) accreditation for its global education platform, Khiron Academy
  • UK medical professionals may now earn CPD credits through Khiron’s medical cannabis education program
  • The Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK, to increase patient access via medical cannabis education
  • As a leading international medical cannabis educator, nearly 1,000 medical professionals in Latin America and the United Kingdom have registered for, or completed, Khiron Academy training

 Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe is pleased to announce it has received UK Continuing Professional Development (“CPD”) accreditation for Khiron Academy, the Company’s global medical cannabis education platform.

Additionally, following its accreditation, the Company has entered into a strategic partnership with Cellen Therapeutics, a leader in digital healthcare in the UK and fellow founding member of Project Twenty21, to increase patient access through medical cannabis education initially. Khiron Academy will be made available to prescribers in the UK that have registered with Cellen’s MedCanHub, an emerging education portal. Cellen is market leader, widely recognized for also launching the UK’s first digital pain clinic, Leva.

Keep reading... Show less

TRACE’s plant-based and alkaline wellness products to expand into key markets of Japan, China and the Philippines

Emerging leader in innovative health and wellness beverages and consumer products, BevCanna Enterprises Inc . ( CSE:BEV , Q:BVNNF , FSE:7BC ) (“ BevCanna ” or the “ Company ”) announces today its anticipated expansion into the Asia Pacific region, through its wholly-owned subsidiary Naturo Group. After completing a comprehensive market, distribution and partner assessment, the Company intends to initially launch its portfolio of TRACE health and wellness products in the key markets of Japan, China, and the Philippines, through multi-channel distribution outlets including e-commerce, retail, and wholesale.

Keep reading... Show less

Trulieve acquires dispensary permits from Solevo Wellness West Virginia LLC for $650,000

Trulieve Cannabis Corp . (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States and the largest cannabis company in Florida announced today that it acquired Solevo Wellness West Virginia LLC (“Solevo”) and its three West Virginia dispensary permits for $650,000 . Solevo was awarded two permits in Morgantown and one in Parkersburg in January 2021 as part of the West Virginia application process.

Keep reading... Show less

Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”) a wellness company that develops and sells sustainable, plant-based products, is pleased to announce that it’s Jusu Home and Body line is now available for purchase on Faire Wholesale Marketplace (“Faire” or “”), an online wholesale marketplace valued at US $2.5 billion. Jusu Home and Body products are currently featured in their “New Arrivals” section.

Cannot view this image? Visit:

Keep reading... Show less

 Aion Therapeutic Inc. (CSE: AION) (” Aion Therapeutic ” or the ” Company “) today announced that it has retained KCSA Strategic Communications (” KCSA “), a leading New York City -based communications firm.

Keep reading... Show less